Evidence map›Paper›PMID 35326710›Full record

ArticleCancers2022

Vitamin D Metabolites in Nonmetastatic High-Risk Prostate Cancer Patients with and without Zoledronic Acid Treatment after Prostatectomy.

Carsten Stephan, Bernhard Ralla, Florian Bonn, Max Diesner, Michael Lein, Klaus Jung

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Human miRNAs in Cancer: Statistical Trends and Cross Kingdom Approach.International journal of molecular sciences · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Carsten StephanDepartment of Urology, Charité-Universitätsmedizin Berlin, 10115 Berlin, Germany.ORCID 0000-0002-3270-258X
Bernhard RallaDepartment of Urology, Charité-Universitätsmedizin Berlin, 10115 Berlin, Germany.
Florian BonnImmundiagnostik AG, 64625 Bensheim, Germany.
Max DiesnerImmundiagnostik AG, 64625 Bensheim, Germany.
Michael LeinDepartment of Urology, Sana Medical Center Offenbach, 63069 Offenbach am Main, Germany.
Klaus JungDepartment of Urology, Charité-Universitätsmedizin Berlin, 10115 Berlin, Germany.ORCID 0000-0001-9797-5362
Charité - Universitätsmedizin Berlin · DEImmundiagnostik (Germany) · DEEcologic Institute · DESana Klinikum Offenbach · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are limited and discrepant data on prostate cancer (PCa) and vitamin D. We investigated changes in three vitamin D

Indexed as

1,25(OH)2D324,25(OH)2D325(OH)D3circulating vitamin D metabolitesprostate cancerprostatectomyvitamin Dzoledronic acid treatment

Identifiers

PMID35326710
PMCPMC8946001
OpenAlexW4221088525

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.